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Abstract
HIV testing and antiretroviral therapy (ART) has scaled 
up tremendously in Malawi in the last 5 years. We analyzed 
trends of  HIV testing uptake in the course of  ART scale-up 
in 25 government and mission hospitals, which were selected 
because they do not receive support from non-governmental 
organizations. Data on numbers of  clients HIV tested and 
on cumulative ART registrations were collected from annual 
country-wide situational analyses and from quarterly ART 
supervisory visits from 2002 to 2007. In the period before 
ART scale up, the quarterly number of  clients HIV tested 
increased from 2609 in 2002 to 8197 in 2004, equivalent to 
an average quarterly increase of  559 tests. During ART scale 
up, the quarterly number of  clients HIV tested increased 
from 17977 in early 2005 to 35344 in the second quarter 
of  2007, equivalent to an average quarterly increase of  2171 
tests. During this time, the cumulative number of  patients 
started on ART increased from 2441 to 29756. There has 
been a rapid acceleration of  HIV testing uptake and ART 
in government and mission hospitals. ART may facilitate 
the decision of  clients to have an HIV test and therefore 
contribute in this way to HIV prevention efforts. 
Introduction
The World AIDS Conference in Durban in 2000 marked a 
turning point in the response by sub-Saharan Africa to the 
HIV/AIDS pandemic. With powerful voices advocating for 
more resources to fight HIV/AIDS and for antiretroviral 
therapy (ART) to be made available for those in need, action 
was taken and increased funds became available for hard hit 
African countries over the next few years1,2.  
Malawi, a small poverty stricken country in Southern 
Africa, has been confronting a severe HIV epidemic for 
two decades. The latest sentinel surveillance data show an 
estimated HIV prevalence in adults of  14% (range 12-17%), 
giving a total of  790,000 infected adults (range 780,000 – 
1,120,000)3. Another 69,000 – 100,000 children are thought 
to be HIV-infected. As a result of  the devastating effects 
of  the epidemic on the country, Malawi was one of  the 
first countries to submit a comprehensive proposal to the 
GFATM, the main focus of  the proposal being the provision 
of  free ART to HIV-infected, eligible patients. In late 2002 
the country received the welcome news that its submission 
was successful. Plans were set in motion for providing ART 
to the country. In 2003, the Ministry of  Health and the 
National AIDS Commission carried out the first country-
wide situational analysis in order to obtain accurate, base-line 
data on numbers of  persons counselled and HIV tested in 
the whole country for the previous year 2002. Since then, 
this activity has taken place without fail every year, and for 
2003 onwards the analysis also includes data on the number 
of  patients placed on ART within the public sector (source 
– HIV Unit, Ministry of  Health, Malawi). 
From 2002 onwards a number of  changes took place that 
influenced HIV testing and counselling in the country. First, 
rapid HIV test kits were introduced into all hospitals in 
Malawi in September 2002, replacing the cumbersome ELISA 
testing system, and there is no doubt that these facilitated 
and eased the practice of  HIV testing from the client’s point 
of  view. Second, the main HIV testing strategy prior to 2002 
was voluntary counselling and HIV testing (VCT), which is 
generally client- or patient- orientated, with the decision left 
entirely with the client about whether to have the test and 
with an emphasis on extensive pre-test counselling and the 
social and preventive implications of  being HIV infected 
or knowing one’s serostatus. In 2002, Kevin de Cock and 
colleagues argued that HIV/AIDS in Africa should be 
redefined as a public health and infectious disease emergency 
with an increased focus on treatment, and they advocated 
for the concept of  routine and diagnostic HIV testing (now 
called “provider-initiated HIV testing) within health-care 
settings4. With this approach, there is greater emphasis on 
“opting-out” (the patients undergo an HIV test as part of  
the service routine unless they specifically decline) rather 
than “opting-in” (patients only have an HIV test if  there is 
a specific request), and there is a higher priority on post-test 
rather than pre-test counselling, particularly if  the patient 
is HIV-positive. Third, the provision of  ART created an 
incentive for HIV testing as treatment was available if  the 
client had a positive HIV test result and was sick. 
Non-governmental organizations (NGOs) that work with 
HIV/AIDS often provide strong leadership and additional 
resources for activities such as HIV testing and HIV 
treatment. We became interested in whether these activities 
were being scaled up in government institutions that receive 
no NGO support, and therefore decided to look at the 
association between the number of  patients tested for 
HIV and the provision of  ART within the government and 




National roll out of  free ART started in June 2004 to a 
few sites in the country, with scale up starting in earnest in 
2005 (source: HIV Unit, Ministry of  Health, Malawi). The 
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details of  ART scale up and the administration of  ART to 
patients has already been described5,6.  In brief, the national 
programme focuses on a simple, standardised approach: use 
of  one generic, fixed dose combination treatment (stavudine, 
lamivudine, nevirapine); a standardised system of  registration, 
monitoring and reporting of  cases and outcomes; and 
quarterly monitoring and supervision visits to all ART sites 
conducted by the HIV Unit of  the Ministry of  Health and 
its partners7. During ART supervision, the supervisors check 
the accuracy, completeness and consistency of  the ART 
register and ART treatment master cards. Cohort analyses 
of  numbers placed on therapy and their outcomes for the 
previous quarter are checked and collected into structured 
proforma. The supervising teams also visit the HIV testing 
and counselling units of  the health facilities providing ART 
and collect data from the HIV Counselling Registers about 
the number of  clients tested, the number HIV-positive 
and the number referred for ART over the course of  the 
previous quarter.  For every ART site in the country, the 
data are entered into an EXCEL data base for the quarter 
in question, and this enables national level aggregation and 
reporting. 
Selection of hospitals, data collection and analysis
The criteria for a hospital ART site to be included in this 
present study were: - i) facilities had to operate under the 
umbrella of  government or CHAM with no support from 
NGOs; ii) facilities had to have been included in all country-
wide situational analysis visits from 2002 to 2006, and iii) 
facilities had to start providing free ART between January and 
April 2005. Data were collected from all selected hospitals 
for the second (Q2) and the fourth (Q4) quarters of  the year 
from 2002 up to June 30th 2007.  
Between 2002 and 2004, before ART was introduced, data 
on numbers of  clients HIV tested were obtained from HIV 
testing registers during the country-wide situational analysis. 
When these data were collected, they were aggregated at the 
time for a 12-month calendar period, and thus the quarterly 
data for this study were calculated (by dividing by 4), assuming 
that HIV testing was uniformly distributed month by month. 
From 2005 onwards, data were obtained on numbers of  
clients HIV tested from HIV testing registers and numbers 
cumulatively started on ART from ART registers during 
quarterly ART supervision visits. 
Ethical approval
This study was not formally submitted for ethical clearance, 
as the Malawi National Health Science Research Committee 
provides general oversight and approval for the collection 
and use of  routine programmatic data for monitoring and 
evaluation. 
Results
The Table shows the annual total of  people HIV tested and 
counselled for the whole country, the number HIV tested and 
counselled in all public sector health facilities and the number 
started on ART for the years 2002 – 2006. The number of  
people HIV tested each year has risen dramatically, and every 
year a growing percentage of  people are being HIV tested in 
health care facilities.
Of  the 25 hospitals selected for the analysis, 5, 12 and 8 
were located in the Northern, Central and Southern Region, 
respectively; 16 were district hospitals and 9 were CHAM 
hospitals. The Figure shows the quarterly number of  
clients HIV tested before the background of  cumulative 
ART registrations, clearly illustrating the acceleration of  
HIV testing from the time of  ART scale-up. In the period 
before ART scale up, the quarterly number of  clients HIV 
tested increased from 2609 in 2002 to 8197 in 2004, which 
is equivalent to an average quarterly increase of  559 tests. 
During ART scale up, the quarterly number of  clients HIV 
tested increased from 17977 in early 2005 to 35344 in the 
second quarter of  2007. This is equivalent to an average 
quarterly increase of  2171 tests. At the same time, the 
cumulative number of  patients started on ART increased 
from 2441 to 29756.
Discussion
HIV testing in the selected health facilities showed a 
moderate but steady increase during the three years prior to 
the introduction of  ART. This may have been due to several 
factors including the need to know about diagnosis of  
HIV in the clinical assessment of  patients, increased public 
awareness of  HIV/AIDS, easier access to HIV testing 
through the provision of  rapid HIV tests, some limited 
provision of  ART in a few facilities and added benefits of  
cotrimoxazole preventive therapy being provided at this time 
to HIV-positive TB patients8. However, the start of  ART 
availability in 2005 marked a turning point in HIV testing 
uptake and was followed by a dramatic acceleration of  HIV 
testing. During both periods, the increase of  testing was 
approximately linear. We believe that this trend is a result 
of  two main initiatives: large efforts placed on scaling up 
HIV testing and counselling services in the country and ART 
being provided at increasing numbers of  health facilities.
The study has the limitations of  this type of  operational 
research. Data were collected from registers used in the 
routine health care system, and it is possible that there 
were errors of  documentation. In the period 2002 – 2004, 
we also do not have quarterly breakdown of  HIV testing 
data, and the extrapolations to quarterly numbers based on 
an assumption of  uniform month to month HIV testing 
may not be valid. However, there were a large number of  
district and mission hospitals selected in all three regions 
of  the country, and these are probably representative of  
government health facilities in the country that are managed 
without NGO support.
It is highly encouraging that ever increasing numbers of  
Table:  HIV testing and counselling and provision of antiretroviral therapy 
in the public sector in Malawi: 2002 – 2006
Year Total number of 
clients HIV 
tested each year 
Number (%) of clients 
HIV tested each year 
in health facilities
Number of new 
patients  placed 
on ART each year
2002 149,540 35,407 (24%) No data
2003 215,269 79,584 (37%) 3,000 (estimate)
2004 283,467 129,199 (46%) 10,183
2005 482,364 302,205 (63%) 24,657
2006 661,400 508,500 (77%) 43,981
HIV Testing and ART in Malawi 6
MMJ 20(1) 2008 www.mmj.medcol.mw
clients and patients are undergoing HIV testing. Knowledge 
of  HIV status is the gateway to care and prevention of  
further infection. Evidence has emerged from Africa on 
the efficacy and cost-effectiveness of  HIV testing and 
counselling in promoting behaviour change and reducing 
the sexual transmission of  HIV 9,10. The outcomes of  HIV-
infected patients in WHO Clinical Stage 3 or 4 without ART 
are very poor11, and there is no doubt that ART greatly 
improves survival12,13, provided the medication is started early 
enough. National programmes must respond to this growing 
demand for HIV testing and ART by ensuring that there are 
no stock-outs of  HIV test kits and drug supplies.   
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